Status:

UNKNOWN

Pulmozyme to Improve COVID-19 ARDS Outcomes

Lead Sponsor:

Boston Children's Hospital

Collaborating Sponsors:

Brigham and Women's Hospital

South Shore Hospital

Conditions:

COVID

Eligibility:

All Genders

3+ years

Phase:

PHASE2

Brief Summary

This is a randomized double-blind placebo-controlled Phase II trial of recombinant human deoxyribonuclease I (rhDNase I) - Pulmozyme - in mechanically ventilated patients with COVID-19 pneumonia. Pat...

Eligibility Criteria

Inclusion

  • ICU admission for pneumonia complicated by respiratory failure.
  • RT-PCR (or equivalent) confirmed COVID-19 infection.
  • Intubated and on mechanical ventilation within 120 hours of initiation of mechanical ventilation.
  • Age ≥ 3 years of age.

Exclusion

  • Allergy or known intolerance to Pulmozyme or Chinese Hamster Ovary cell products
  • History of moderate to severe asthma, cystic fibrosis, or severe COPD (baseline FEV1 ≤ 40% predicted)
  • Active malignancy other than basal cell melanoma or in situ breast cancer
  • Unstable angina
  • Chronic liver disease as judged by the investigator that would pose significant risk to participation
  • Chronic renal disease as judged by the investigator that would pose significant risk to participation
  • Inability to obtain informed consent from patient or legally authorized representative (LAR)
  • Pregnant or breastfeeding Use of extracorporeal membrane oxygenation (ECMO)
  • Prisoner status
  • Concurrent treatment with other inhaled investigational agent for COVID-19\*\*
  • Patient, surrogate, or physician not committed to full support (exception: a patient will not be excluded if he/she would receive all supportive care except for attempts at resuscitation from cardiac arrest)
  • Moribund patient not expected to survive 24 hours
  • Active hemoptysis

Key Trial Info

Start Date :

July 5 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2021

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04402944

Start Date

July 5 2020

End Date

December 31 2021

Last Update

December 17 2021

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Boston Children's Hospital

Boston, Massachusetts, United States, 02115

2

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

3

South Shore Hospital

Weymouth, Massachusetts, United States, 02190

Pulmozyme to Improve COVID-19 ARDS Outcomes | DecenTrialz